Global Zafirlukast Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Zafirlukast Market Research Report 2024
Zarlukast is a white solid with a melting point (º C) of 139. Its solubility is slightly soluble in methanol, soluble in tetrahydrofuran, acetone and dimethyl sulfoxide, and almost insoluble in water. Clinically, zarlukast is a leukotriene receptor antagonist, and its indication is the prevention and long-term treatment of asthma.
According to Mr Accuracy reports’s new survey, global Zafirlukast market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Zafirlukast market research.
Key companies engaged in the Zafirlukast industry include Target Molecule Corp., Merck, Cayman Chemical Company, APExBIO Technology LLC, Carbosynth Ltd, Biorbyt, Toronto Research Chemicals, Glr Innovations and Medical Isotopes, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Zafirlukast were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Zafirlukast market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Zafirlukast market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Target Molecule Corp.
Merck
Cayman Chemical Company
APExBIO Technology LLC
Carbosynth Ltd
Biorbyt
Toronto Research Chemicals
Glr Innovations
Medical Isotopes, Inc.
AvaChem Scientific
Tokyo Chemical Industry Co.,Ltd.
Carbone scientific
Santa Cruz Biotechnology, Inc.
Chemos GmbH and Co. KG
3B Scientific
MedChemExpress LLC
AK Scientific, Inc.
CarboMer, Inc.
Creative Enzymes
Combi-Blocks
Chromo Laboratories India Pvt Ltd
Dr.Reddy's Laboratories Limited
Shanghai Beilang Biotechnology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Shanghai Acmec Biochemical Co.,Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Dalian Meilun Biotechnology Co., Ltd
BOC Sciences
Standardpharm Co., Ltd.
Aibixin (Shanghai) Biotechnology Co., Ltd
Glpbio
Abmole Bioscience Inc.
Segment by Type
10 mg
20 mg
Leukotriene Antagonist
Treatment of Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Zafirlukast report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Zafirlukast market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Zafirlukast market research.
Key companies engaged in the Zafirlukast industry include Target Molecule Corp., Merck, Cayman Chemical Company, APExBIO Technology LLC, Carbosynth Ltd, Biorbyt, Toronto Research Chemicals, Glr Innovations and Medical Isotopes, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Zafirlukast were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Zafirlukast market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Zafirlukast market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Target Molecule Corp.
Merck
Cayman Chemical Company
APExBIO Technology LLC
Carbosynth Ltd
Biorbyt
Toronto Research Chemicals
Glr Innovations
Medical Isotopes, Inc.
AvaChem Scientific
Tokyo Chemical Industry Co.,Ltd.
Carbone scientific
Santa Cruz Biotechnology, Inc.
Chemos GmbH and Co. KG
3B Scientific
MedChemExpress LLC
AK Scientific, Inc.
CarboMer, Inc.
Creative Enzymes
Combi-Blocks
Chromo Laboratories India Pvt Ltd
Dr.Reddy's Laboratories Limited
Shanghai Beilang Biotechnology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Shanghai Acmec Biochemical Co.,Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Dalian Meilun Biotechnology Co., Ltd
BOC Sciences
Standardpharm Co., Ltd.
Aibixin (Shanghai) Biotechnology Co., Ltd
Glpbio
Abmole Bioscience Inc.
Segment by Type
10 mg
20 mg
Segment by Application
Leukotriene Antagonist
Treatment of Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Zafirlukast report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
